德国的大麻使用情况
Daniel Kotz1, Sabrina Kastaun, Jakob Manthey
1Institute of General Practice (ifam), Addiction Research and Clinical Epidemiology Unit, Centre for Health and Society (chs), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf; Department of Behavioural Science and Health, University College London, London, UK; Institute of General Practice (ifam), Patient-Physician Communication Research Unit, Centre for Health and Society (chs), Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf; Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf (UKE); Department of Psychiatry, Medical Faculty, University of Leipzig; IFT Institut für Therapieforschung, Center for Mental Health and Addiction Research, Munich; Department of Psychology, Division of Clinical Psychology and Psychological Treatment, Ludwig-Maximilans-Universität München, Munich; Department of Psychiatry and Psychotherapy, Cannabinoid Research Group, University Hospital, LMU Munich, Munich.
德国 德国 德国 德国
科学领域:
- 公共卫生 公共卫生
- 药物使用研究研究 药物使用研究
- 大麻政策 大麻政策 大麻政策
背景情况:
- 德国正准备将成人娱乐大麻合法化.
- 关于大麻使用模式的基线数据对于公共卫生规划至关重要.
- 了解与尼古丁/烟草的共同使用对于减少危害至关重要.
研究的目的:
- 评估德国过去一年大麻使用率的流行情况.
- 为了确定大麻管理的首选途径.
- 检查大麻与尼古丁或烟草制品的共同使用情况.
主要方法:
- 一项针对9644名年龄在14岁及以上的个人进行的国家调查的分析.
- 关于过去一年大麻消费的自我报告数据.
- 评估最喜欢的给药途径 (吸烟,消费等). ) 的情况.
主要成果:
- 去年大麻使用率为4.6%,较年轻年龄组 (14-24岁) 的使用率更高.
- 与烟草或没有烟草一起吸食大麻是主要的给药方法 (92.4%).
- 尼古丁/烟草产品的共同使用者,特别是水管使用者,显示大麻使用率明显更高 (27.0%).
结论:
- 吸烟仍然是大麻消费的主要方式,特别是在年轻人中.
- 预防和减少危害的策略对于减轻大麻相关风险至关重要.
- 需要持续监测,以评估即将在德国合法化大麻的影响.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Psychedelic Agents


